Dr. Ting Niu: Population-based study reveals prognostic factors and clinical characteristics of gray zone lymphoma patients
From June 8th to 11th, 2023, the 28th European Hematology Association (EHA) annual conference was held grandly in Frankfurt, Germany. The EHA conferences have always been spectacular, with research on lymphoma consistently attracting significant attention. A study on gray zone lymphoma by Dr Ting Niu's team from West China Hospital of Sichuan University ( Abstract No.: P1198) was selected for this EHA. The research aimed to summarize the clinical characteristics and factors influencing the prognosis of gray zone lymphoma by reviewing the relevant data in the SEER database. To gain a deeper understanding of the research, Oncology Frontier invited Dr Niu to provide aninterpretation as below.